Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Abbott patents novel RNA-directed RNA polymerase inhibitors

Oct. 9, 2006

AVI-4065 results in HCV lead to protocol modification

Oct. 6, 2006

Pylera receives approval letter for eradication of H. pylori

Oct. 3, 2006

NOV-205 evaluated for hepatitis C in first U.S. study

Oct. 3, 2006

NS5B RNA-dependent RNA polymerase inhibitors reported by Biota

Oct. 2, 2006

Axcan and AGI sign license and codevelopment agreement for AGI-010

Oct. 2, 2006

New NK2 receptor antagonist with potential use in IBS

Sep. 29, 2006

InterMune files to begin phase I program for HCV protease inhibitor ITMN-191

Sep. 29, 2006

Optimized IC-41 regimen studied in proof-of-concept trial for hepatitis C

Sep. 28, 2006

Improved oral bioavailability with HepDirect nucleoside prodrugs for the treatment of HCV infection

Sep. 26, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...